During the past decade, Northwest Alabama Cancer Center conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 10 clinical trials were completed, i.e. on average, 333.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Northwest Alabama Cancer Center" #1 sponsor was "Bristol-Myers Squibb" with 6 trials, followed by "Celgene" with 2 trials sponsored, "Helsinn Healthcare SA" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "CTI BioPharma" with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northwest Alabama Cancer Center" #1 collaborator was "Parexel" with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Astex Pharmaceuticals, Inc." with 1 trials as a collaborator, "Bionomics Limited" with 1 trials as a collaborator and "Cephalon" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Northwest Alabama Cancer Center" are "Advanced Cancer" (2 trials), "Chemotherapy-Induced Nausea and Vomiting" (2 trials), "Multiple Myeloma" (2 trials), "Pancreatic Cancer" (2 trials) and "Renal Cell Carcinoma" (2 trials). Many other conditions were trialed in "Northwest Alabama Cancer Center" in a lesser frequency.

Most popular intervention types in "Northwest Alabama Cancer Center" are "Drug" (23 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Dexamethasone" (3 trials), "Cetuximab" (2 trials), "Gemcitabine" (2 trials), "Ipilimumab" (2 trials) and "Netupitant and Palonosetron" (2 trials). Other intervention names were less common.

The vast majority of trials in "Northwest Alabama Cancer Center" are 25 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Northwest Alabama Cancer Center". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Northwest Alabama Cancer Center, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Northwest Alabama Cancer Center, 4 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".